(Q33503311)

27 July 2017

1 reference

title

Adverse haematological effects of ticlopidine. Prevention, recognition and management (English)

1 reference

27 July 2017

B B Love

1

1 reference

27 July 2017

J Biller

series ordinal

2

1 reference

27 July 2017

M Gent

series ordinal

3

1 reference

27 July 2017

language of work or name

1 reference

1 August 1998

1 reference

27 July 2017

1 reference

27 July 2017

19

1 reference

27 July 2017

2

1 reference

27 July 2017

89-98

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199819020-00002

27 July 2017

0 references

cites work

Platelet inhibitor agents in cardiovascular disease: an update

1 reference

12 December 2020

Reversible bone-marrow suppression primarily involving granulopoiesis following the use of Ticlopidine

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura related to ticlopidine

1 reference

12 December 2020

Pharmacology of ticlopidine: a review

1 reference

12 December 2020

Fatal neutropenia and thrombocytopenia associated with ticlopidine

1 reference

12 December 2020

Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine après Pontage Fémoro-Poplité and the Association Universitaire de Recherche en Chirurgie

1 reference

12 December 2020

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

12 December 2020

A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects

1 reference

12 December 2020

Effects of ticlopidine, a new platelet antiaggregating agent, and its analogues on mitochondrial metabolism. Oxidative phosphorylation, protein synthesis and DNA polymerase activity

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with ticlopidine

1 reference

12 December 2020

Aplastic anemia associated with ticlopidine

1 reference

12 December 2020

Treatment of thrombotic thrombocytopenic purpura. Evaluation of plasma exchange and review of the literature

1 reference

12 December 2020

Agranlocytosis caused by ticlopindine and its mechanism

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

Aplastic anemia with ticlopidine therapy in two Chinese patients

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura caused by ticlopidine, successfully treated by plasmapheresis

1 reference

12 December 2020

Ticlopidine and thrombocytopenia

1 reference

12 December 2020

Delayed neutropenia with ticlopidine

1 reference

12 December 2020

Cerebral hemorrhage and thrombotic thrombocytopenic purpura during ticlopidine treatment: case report

1 reference

12 December 2020

Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia

1 reference

12 December 2020

Comparative effects of ticlopidine and analogues on in vitro myeloid colony (CFU-GM) growth

1 reference

12 December 2020

Granulocyte colony-stimulating factor for neutropenia secondary to ticlopidine

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with ticlopidine

1 reference

12 December 2020

Comment: Pseudomonas bacteremia secondary to ticlopidine-induced agranulocytosis

1 reference

12 December 2020

Blood dycrasias and hematologic reactions in ticlopidine users

1 reference

12 December 2020

Sustained granulocyte recovery after G-CSF in a patient with ticlopidine-induced severe aplastic anemia

1 reference

12 December 2020

[Bone marrow culture in patients treated with Ticlopidine]

1 reference

12 December 2020

Aplastic anemia and ticlopidine

1 reference

12 December 2020

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

1 reference

12 December 2020

Ticlopidine and severe aplastic anaemia

1 reference

12 December 2020

Ticlopidine and severe aplastic anaemia

1 reference

12 December 2020

Hematological toxicity of ticlopidine

1 reference

12 December 2020

Ticlopidine and severe aplastic anemia

1 reference

12 December 2020

Bone marrow aplasia associated with ticlopidine therapy

1 reference

12 December 2020

Ticlopidine and fatal aplastic anemia in an elderly woman

1 reference

12 December 2020

Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states

1 reference

12 December 2020

Neutropenia with ticlopidine plus aspirin

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

Ticlopidine and aplastic anaemia

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura developed during ticlopidine therapy

1 reference

12 December 2020

10.2165/00002018-199819020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference